Chemours Announces Board and Executive Changes
Ticker: CC · Form: 8-K · Filed: Jun 5, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $600,000, $50,000, $1,000,000, $500,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: CC
TL;DR
Chemours is shuffling its board and exec comp. Watch for strategic shifts.
AI Summary
On May 31, 2024, The Chemours Company filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for key executives. Specific details regarding the individuals involved and the financial implications of these changes are outlined within the report.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation structures can introduce uncertainty regarding future strategy and financial performance.
Key Players & Entities
- The Chemours Company (company) — Registrant
- Delaware (location) — State of Incorporation
- May 31, 2024 (date) — Date of Report
FAQ
What specific roles have been affected by the departure of officers?
The filing indicates the departure of certain officers, but does not specify their exact roles or titles within this summary section.
Who are the newly elected directors?
The filing mentions the election of new directors but does not list their names in the provided text.
What are the key changes in compensatory arrangements?
The filing notes updates to compensatory arrangements for certain officers, but the specific details of these arrangements are not provided in this excerpt.
What is the primary reason for these board and executive changes?
The filing does not explicitly state the primary reason for these changes, only that they are being reported under the relevant SEC form items.
When was the previous company name change for Chemours?
The former company name, Chemours Company, LLC, changed to The Chemours Company on December 5, 2014.
Filing Stats: 750 words · 3 min read · ~3 pages · Grade level 11.5 · Accepted 2024-06-05 06:37:34
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
- $600,000 — r will receive an annual base salary of $600,000, a signing bonus of $50,000, a target a
- $50,000 — salary of $600,000, a signing bonus of $50,000, a target annual bonus opportunity of 7
- $1,000,000 — incentive ("LTI") award opportunity of $1,000,000. In addition, in respect of his service
- $500,000 — having an aggregate grant date value of $500,000, representing a prorated 2024 LTI award
Filing Documents
- cc-20240531.htm (8-K) — 47KB
- cc-ex99_1.htm (EX-99.1) — 23KB
- img15408389_0.jpg (GRAPHIC) — 37KB
- img172685040_0.jpg (GRAPHIC) — 35KB
- 0000950170-24-069063.txt ( ) — 328KB
- cc-20240531.xsd (EX-101.SCH) — 29KB
- cc-20240531_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated as of June 5, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Matthew S. Abbott Matthew S. Abbott Interim Chief Financial Officer Date: June 5, 2024